C. Pandolfini and M. Bonati, A literature review on off-label drug use in children, Eur J Pediatr, vol.164, pp.552-560, 2005.

E. Parliament, Regulation (EC) No 1901/2006 of the european parliament and of the council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive, Official Journal of the European Union, issue.726, 1901.

R. G. Strickley, Q. Iwata, S. Wu, and T. C. Dahl, Pediatric drugs -a review of commercially available oral formulations, J Pharm Sci, vol.97, pp.1731-74, 2008.

M. Carvalho, K. Taylor, and C. Tuleu, Why do we need hospital pharmacy preparation ?, EJHP, vol.19, pp.467-468, 2012.

A. Brayfield and . Martindale, The Complete Drug Reference, p.4792, 2017.

H. S. Bada, T. Sithisarn, J. Gibson, K. Garlitz, R. Caldwell et al., Morphine versus clonidine for neonatal abstinence syndrome, Pediatrics, vol.135, pp.383-91, 2015.

A. G. Agthe, G. R. Kim, K. B. Mathias, C. W. Hendrix, R. Chavez-valdez et al.,

M. Yaster and E. B. Gauda, Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial, Pediatrics, vol.123, pp.849-56, 2009.

B. Surran, P. Visintainer, S. Chamberlain, K. Kopcza, B. Shah et al., Efficacy of clonidine versus phenobarbital in reducing neonatal morphine sulfate therapy days for neonatal abstinence syndrome. A prospective randomized clinical trial, J Perinatol, vol.33, pp.954-963, 2013.

T. C. Mastenbroel, B. J. Kramp-hendriks, J. W. Kallewaard, and J. M. Vonk, Multimodal intrathecal analgesia in refractory cancer pain, Scand J Pain, vol.14, pp.39-43, 2017.

P. Lambert, A. M. Cyna, N. Knight, and P. Middleton, Clonidine premedication for postoperative analgesia in children, Cochrane Database Syst Rev, vol.28, p.9633, 2014.

V. W. Yeung and I. C. Wong, When do children convert from liquid antiretroviral to solid formulations?, Pharm World Sci, vol.27, pp.399-402, 2005.

T. Sam, T. B. Ernest, J. Walsh, and J. L. Williams, A benefit/risk approach towards selecting appropriate pharmaceutical dosage forms -An application for paediatric dosage form selection, Int J Pharm, vol.435, pp.115-138, 2012.

, European Medicines Agency: Committee for medicinal products for human use. Reflection paper: formulations of choice for the paediatric population. 28 juil, 2006.

A. L. De-goede, R. R. Boedhram, M. Eckhardt, L. M. Hanff, B. Koch et al.,

, Development and validation of a paediatric oral formulation of clonidine hydrochloride, Int J Pharm, vol.433, pp.119-139, 2012.

M. Ensom and D. Decarie, Stability of Extemporaneously Compounded Clonidine in Glass and Plastic Bottles and Plastic Syringes, Can J Hosp Pharm, vol.67, pp.308-318, 2014.

M. L. Levinson and C. E. Johnson, Stability of an extemporaneously compounded clonidine hydrochloride oral liquid, Am J Hosp Pharm, vol.49, pp.122-125, 1992.

C. Ma, D. Decarie, and M. Ensom, Stability of Clonidine Suspension in Oral Plastic Syringes, Am J Health-Syst Pharm, vol.71, pp.657-61, 2014.

J. B. Sauberan, P. Phuong, N. D. Ilog, and S. S. Rossi, Stability and osmolality of extemporaneously prepared clonidine oral liquid for neonates, Ann Pharmacother, vol.50, pp.244-249, 2016.

J. R. Byford, L. E. Shaw, M. Drew, G. S. Pope, M. J. Sauer et al., Oestrogenic activity of parabens in mcf7 human breast cancer cells, J Steroid Biochem Mol Biol, vol.80, pp.49-60, 2002.

M. Namer, E. Luporsi, J. Gligorov, F. Lokiec, and M. Spielmann,

, Bull Cancer, vol.95, pp.871-880, 2008.

S. Oishi, Effects of butylparaben on the male reproductive system in rats, Toxicol Ind Health, vol.17, pp.31-39, 2001.

S. Oishi, Effects of butyl paraben on the male reproductive system in mice, Arch Toxicol, vol.76, pp.423-429, 2002.

C. Tuleu and J. Breitkreutz, Educational paper: formulation-related issues in pediatric clinical pharmacology, Eur J Pediatr, vol.172, pp.717-737, 2013.

G. Sfpc, Methodological guidelines for stability studies of hospital pharmaceutical preparations, 2013.

P. Hubert, J. Nguyen-huu, B. Boulanger, E. Chapuzet, P. Chiap et al., Harmonization of strategies for the validation of quantitative analytical procedures, J Pharm Biomed Anal, vol.45, pp.70-81, 2007.

P. Hubert, J. Nguyen-huu, B. Boulanger, E. Chapuzet, N. Cohen et al., Harmonization of strategies for the validation of quantitative analytical procedures, J Pharm Biomed Anal, vol.45, pp.82-96, 2007.

P. Hubert, J. Nguyen-huu, B. Boulanger, E. Chapuzet, P. Chiap et al., Harmonization of strategies for the validation of quantitative analytical procedures, J Pharm Biomed Anal, vol.36, pp.579-86, 2004.

P. Hubert, J. Nguyen-huu, B. Boulanger, E. Chapuzet, N. Cohen et al., Harmonization of strategies for the validation of quantitative analytical procedures: A SFSTP proposal, J Pharm Biomed Anal, vol.48, pp.760-71, 2008.

. Ich-guidelines, European Pharmacopeia 9 th , 2017. 5.1.4 "Microbiological quality of non-sterile pharmaceutical preparations and substances for pharmaceutical use, R1, vol.2, 2005.

, European Pharmacopeia 9 th , 2017. 2.6.12 "microbiological examination of non-sterile products: microbial enumeration tests" monograph

, European Pharmacopeia 9 th , 2017. 2.6.13 "microbiological examination of non-sterile products: tests for specified micro-organisms

P. J. Sheskey, . Cook, . Wg, and C. G. Cable, Handbook of pharmaceutical excipients. Monograph potassium sorbate, 1216.

A. M. Classen, G. H. Wimbish, and T. C. Kupiec, Stability of Admixture Containing Morphine

B. Sulfate and . Hydrochloride, Clonidine Hydrochloride in an Implantable Infusion System, J Pain and Symptom Manag, vol.28, pp.603-614, 2004.

K. R. Hildebrand, D. D. Elsberry, and S. J. Hassenbusch, Stability and compatibility of morphineclonidine admixtures in an implantable infusion system, J Pain Symptom Manag, vol.25, pp.464-471, 2003.

D. Shields and R. Montenegro, Chemical Stability of Ziconotide-Clonidine Hydrochloride Admixtures with and without Morphine Sulfate during Simulated Intrathecal Administration, Neuromodulation, vol.10, pp.6-11, 2007.

L. A. Trissel, Q. A. Xu, and S. J. Hassenbusch, Development of Clonidine Hydrochloride Injections for Epidural and Intrathecal Administration, Int J Pharm Compd, vol.1, pp.274-281, 1997.

Q. A. Xu, L. A. Trissel, and L. Pham, Physical and Chemical Stability of Low and High Concentrations of Morphine Sulfate with Clonidine Hydrochloride Packaged in Plastic Syringes, Int J Pharm Compd, vol.6, pp.66-75, 2002.

P. Satyanarayana and G. V. Adilakshmi, Stability indicating isocratic RP-HPLC method development and validation for the simultaneous analysis of clonidine and chlorthalidone in pharmaceutical formulation, Indo Am J Pharm Res, vol.5, pp.3226-3262, 2015.

A. Dahan, A. Dahan, J. M. Miller, and G. L. Amidon, Prediction of solubility and permeability class membership: provisional BCS classification of the world's top oral drugs, AAPS, vol.11, issue.4, pp.740-746, 2009.

S. M. Hanning, O. Gul, M. , T. I. Neubert, A. Tuleu et al., CloSed Consortium. A mini-review of non-parenteral clonidine preparations for paediatric sedation, J Pharm Pharmacol, vol.69, pp.398-405, 2017.

, The fourth report on the Diagnosis, evaluation, and treatment of high blood pressure in children and adolescents, Pediatrics, vol.114, pp.555-576, 2004.